Drawing for IMMUNOSYS

USPTO serial 76249192

IMMUNOSYS

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
RIRIE, VERNA BETH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMMUNOSYS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia B. Summerfield

CYNTHIA B SUMMERFIELD PHARMACIA CORPORATION100 RTE 206 NPEAPACK, NJ 07977UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents and diagnostic preparations for in vitro scientific or research use in laboratories and in industryACTIVE—
005Chemical reagents and diagnostic preparations for in vitro clinical medical use in veterinary laboratories; clinical medical chemical reagents for veterinary purposes; chemical reagents for in vivo use; diagnostic preparations clinical or medical laboratory purposeACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 2, 2002ABN1ABANDONMENT - EXPRESS MAILED—
Oct 9, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 14, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 31, 2001DOCKASSIGNED TO EXAMINER—
Jul 27, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance